Effects and cost of glycyrrhizin in the treatment of upper respiratory tract infections in members of the Japanese maritime self-defense force: Preliminary report of a prospective, randomized, double-blind, controlled, parallel-group, alternate-day treatment assignment clinical trial.

Background: Upper respiratory tract infections (URTIs) account for at least half of all acute illnesses. Specific antiviral therapy has not been developed against most respiratory viruses thought to cause URTIs. The pharmacologic action of glycyrrhizin has been shown to produce anti-inflammatory activity, modulation of the immune system, inhibition of virus growth, and inactivation of viruses.

[A case of moyamoya disease diagnosed by cerebral ischemic symptoms induced by anti-hypertensive therapy].

We presented a case in which anti-hypertensive therapy inducing cerebral ischemia led to a diagnosis of moyamoya disease. In cases presenting cerebral ischemia due to the lowering of high systemic blood pressure, it is necessary to make a differential diagnosis of a disease causing hemodynamic cerebral insufficiency.

[A case of thoracic spondylosis presented with an attack of abnormal sensation and hyperhydrosis on the upper back].

A 23-year-old man presented an attack of abnormal sensation and hyperhydrosis on his upper back when he was tense or took a bath. This presentation continued for a month after commencement of Judo practise. Neurological examination found hyperactivity of bilateral deep tendon reflex alone.

[An operated case of Mycobacterium fortuitum infection with hemoptysis].

An operated case of M. fortuitum infection on the bronchiectatic lung was presented. A 68-year-old female had had hemoptysis due to bronchiectasis since she was 44 years of age.